- Using health technology assessment to inform insurance reimbursement of high technology medicines in China: an example of cancer immunotherapy The BMJ
- Use of health technology assessment in drug reimbursement decisions in China The BMJ
- Use of real world data to improve drug coverage decisions in China The BMJ
- Health technology assessment to inform decision making in China: progress, challenges, and sustainability The BMJ
- How health technology reassessment can support disinvestment in China’s national drug reimbursement list The BMJ
- View Full Coverage on Google News
Source link